期刊文献+

重视角膜移植术后免疫排斥反应的防治 被引量:28

Emphasizing the prevention and treatment of immune rejection after corneal transplantation
原文传递
导出
摘要 角膜移植术是角膜病盲人复明的最主要手段,但术后的免疫排斥反应仍是手术失败的最主要原因。随着我国医疗水平的不断提高,开展角膜移植手术的医院也不断增加。而如何减少术后的并发症和提高植片的长期透明率,是摆在众多从事角膜移植医师面前的一个重要问题。保持角膜移植术后植片长期透明的核心问题是重视术后随诊和免疫排斥反应的防治。本文主要从我国角膜移植的现状、存在的问题及如何减少免疫排斥反应的措施三个主要方面进行分析,并对目前角膜移植术后存在的一些普遍问题提出相应的处理措施和建议,以达到减少角膜移植术后由免疫排斥反应导致植片混浊的再次致盲问题。 Corneal transplantation is a major therapeutic method to recover the sight from corneal blindness, however, the immune rejection is still the major impact factor for graft failure. With the improvement of the medical care in our country, corneal transplantation has been increased continually. Therefore, reducing the complications and increasing the long-term tranparency rate of the graft is an important mission for ophthalmologists, The key core of the corneal transplantation is to pay more attention to the follow-up and prevent the immune rejecton, Three respects, including the current status and problems of corneal transplantation in China, the update immune refection theory and the means of reducing the immunce refecton of the corneal graft, and the methods to reduce the risk of blindness due to immunce rejection, will be focused in this paper.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2006年第1期3-5,共3页 Chinese Journal of Ophthalmology
关键词 角膜移植 移植物排斥 角膜疾病 Corneal transplantation Graft rejection Corneal diseases
  • 相关文献

参考文献16

二级参考文献46

  • 1谢立信.眼前段碱性化学伤的后期治疗(一)[J].眼外伤职业眼病杂志,1994,16(3):237-239. 被引量:4
  • 2谢立信,董晓光.桥式角膜植片在治疗性穿透性角膜移植术中的应用[J].眼科新进展,1989,9(4):17-19. 被引量:2
  • 3谢立信,曹景,董晓光,杨雪萍.环孢霉素A和地塞米松局部应用对角膜移植免疫排斥的疗效观察[J].眼科研究,1995,13(1):24-26. 被引量:8
  • 4谢立信 董晓光 等.穿透性角膜移植术植片混浊的发生规律探讨[J].眼科新进展,1987,3:42-43.
  • 51,Wilson SE,Kaufman HE.Graft failure after penetrating keratoplasty.Sur Ophthalmol,1990,34∶325
  • 62,Khodadoust AA,Silverstein AM.Transplantation and rejection of individual layers of the cornea.Invest Ophthalmol Vis Sci,1969,8∶180
  • 73,Krachmer JH,Alldredge OC.Subepithelial infiltrates probable sign of corneal transplant rejection.Arch Ophthalmol,1978,96∶2234
  • 84,Khodadoust AA,Silverstein AM.Studies of the nature of the privilege enjoyed by corneal allografts.Invest Ophthalmol Vis Sci,1972,11∶137
  • 95,Price FW,Whitson WE,Collins KS,et al.Five year corneal graft survival.A large single-center patient cohort.Arch Ophthalmol,1993,111∶799
  • 106,Hill JC.Systemic cyclosporine in high-risk keratoplasty.Ophthalmology,1994,101∶128

共引文献150

同被引文献323

引证文献28

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部